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Background: A set of 700 compounds found active after the
whole cell screening of 20,000 compounds library againstMycobac-
terium tuberculosis H37Rv was screened in the ATP synthase assay.
Three compounds showed promising IC50 and were further eval-
uated in the time kill assay and combination studies with ﬁrst line
anti-TB drugs against M tuberculosis H37Rv. The compounds were
tested for cytotoxicity against HepG-2 cell lines
Methods&Materials: ATP synthase assaywas performed using
the inverted membrane vesicles of Mycobacterium smegmatis for
the screening of the 700 compounds by estimating the ATP pro-
duction. In-vitro activities of the selected compounds were done
by microdilution method, cell toxicity proﬁle using MTT assay in
HepG2 cell line, in vitro time kill assay and combinational studies
with ﬁrst line drugs.
Results: Three compounds C1-C3 showing promising inhibitory
activity (IC50 values 0.13-4.0 M) in the in-vitro ATP synthase
inhibition assay also exhibited potent anti-mycobacterial activity
(MIC-0.06-2.0g/ml). These compounds were nontoxic in HepG2
cell line, Compound C1 was bactericidal at 8X MIC (1 g/ml) and
exhibited synergistic activity with rifampicin.
Conclusion: ATP synthase screening of whole cell active com-
pounds from IIIM repository led to the identiﬁcation of three
compounds showing good inhibitory activity against ATP syn-
thase. All the compounds displayed promising anti-mycobacterial
potential with no detected toxicity against mammalian cell line.
Compound (C1) showed synergistic activitywith rifampicin, which
forms the backbone of anti-TB therapy. These compounds repre-
sents novel chemotypes against ATP synthase and can be taken up
for medicinal chemistry efforts.
http://dx.doi.org/10.1016/j.ijid.2016.02.832
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Clinical proﬁle and evaluation of diagnostic
tests in culture positive childhood tuberculosis
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Background: Tuberculosis (TB) ranks among the ten major
causes of mortality among children. The diagnosis of childhood TB
remains quite challenging. Mycobacterial culture is the gold stan-
dard in diagnosis; however, positive cultures are seen only in 50%.
The aim was to study the clinical proﬁle and sensitivity of other
diagnostic tests in culture-proven tuberculosis in children.
Methods & Materials: Retrospective chart review of children
with culture-proven Tuberculosis diagnosed in the Department
of Pediatrics, Christian Medical College, Vellore, India between
January 2003 to January 2007.
Results: There were 61 cases of culture-conﬁrmed TB (32 boys
and 29 girls). The mean age at diagnosis was 7.8±5 years. His-
tory of contact with TB was present in 14 children. The major
presenting symptoms included fever (78%), cough (49%), loss of
appetite (36%) and loss of weight (24%). Pulmonary Tb was seen
in 22 children (36%) and extra-pulmonary TB in 39(64%). Dissem-
inated TB was seen in 46%. Two children tested positive for HIV.
Results of Drug susceptibility testing was available for only 41/61
children. Four children had MDR TB; none had XDR TB. All children
were started on daily anti-tuberculous therapy. Of the 61 children,
26 were cured, 26 children were referred elsewhere for treat-
ment, and 9 children died or were discharged in a moribund state
(14.8%). There was no signiﬁcant difference in treatment outcome
between the pulmonary and extra pulmonary group (p=0.393). The
sensitivity of ESR was 96% and Mantoux was 69.2% in the over-
all group. In culture-conﬁrmed pulmonary TB, sensitivity of chest
X-ray was 95.5% and AFB smear was 45.5%. In culture-conﬁrmed
extra-pulmonary TB, sensitivity of AFB smear was 38.5% and that
of biopsy was 25%.
Conclusion: The majority of culture-conﬁrmed TB at this ter-
tiary care center was extra-pulmonary TB, with a high incidence
of disseminated disease. Drug-resistant TB was seen in only a few
children. The sensitivity of AFB smear,Mantoux and biopsy inmak-
ing the diagnosis was quite low. ESR was highly sensitive but this
test is highly nonspeciﬁc and elevated in many diseases.
http://dx.doi.org/10.1016/j.ijid.2016.02.833
